Current and Emerging Infectious Risks of Blood Transfusions

JAMA

Volumn 289, Issue 8, 2003, Pages 959-962

  Busch, Michael P ^a,b,f   Kleinman, Steven H ^c,d   Nemo, George J ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Blood Systems Incorporated   (United States)

^c WESTAT   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f Blood Centers of the Pacific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION RISK; MALARIA; MICROBIAL CONTAMINATION; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; REVIEW; SAFETY; SCREENING TEST; SERODIAGNOSIS; TRYPANOSOMA CRUZI; VIREMIA; VIRUS INFECTION; WEST NILE FLAVIVIRUS; ARTICLE; BLOOD; BLOOD BANK; BLOOD DONOR; BLOODBORNE BACTERIUM; CHAGAS DISEASE; COMMUNICABLE DISEASE; DEVELOPED COUNTRY; DEVELOPING COUNTRY; ECONOMICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; RISK; STANDARD; VIRUS HEPATITIS;

VIRUS DNA;

BLOOD BANKS; BLOOD DONORS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; CHAGAS DISEASE; COMMUNICABLE DISEASES, EMERGING; CREUTZFELDT-JAKOB SYNDROME; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DNA, VIRAL; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; MALARIA; RISK; SAFETY;

EID: 0037466923     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.8.959     Document Type: Review

References (28)

1. Kleinman SH, Busch MP. The risks of transfusion-transmitted infection: direct estimation and mathematical modeling. In: Contrera M, ed. Baillere's Best Practice and Research Clinical Haematology, New Aspects of Blood Transfusion. London, England: Baillière Tindall; 2000;13(4):631-649.
2. Busch MP. Closing the windows on viral transmission by blood transfusion. In: Stramer SL, ed. Blood Safety in the New Millennium: AABB 2000 Emily Cooley Seminar Book. Bethesda, Md: AABB Press; 2001:33-54.
3. Jackson BR, Busch MP, Stramer SL, et al. The cost-effectiveness of nucleic acid testing for HIV, hepatitis C virus and hepatitis B virus in whole blood donations. Transfusion. In press.
4. Busch MP, Dodd RY. Nucleic acid amplification testing and blood safety: what is the paradigm [editorial]? Transfusion. 2000;40:1157-1160.
5. Stramer SL, Caglioti S, Strong DM. NAT of the United States and Canadian blood supply. Transfusion. 2000;40:1165-1168.
6. Weinberg PD, Hounshell J, Sherman LA, et al. Legal, financial, and public health consequences of HIV contamination of blood and blood products in the 1980s and 1990s. Ann Intern Med. 2002;136:312-319.
7. Delwart EL, Kalmin ND, Jones TS, et al. First report of HIV transmission via an RNA-screened blood donation. Transfusion. In press.
8. Kleinman SH, Busch MP. HBV: amplified and back in the blood safety spotlight [editorial]. Transfusion. 2001;41:1081-1085.
9. Schmidt I, Blumel J, Seitz H, Willkommen H, Lower J. Parvovirus B19 DNA in plasma pools and plasma derivatives. Vox Sang. 2001;81:228-235.
10. Centers for Disease Control and Prevention. Update: investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion-Michigan, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:879.
11. Jacobs MR, Palavecino E, Yomtovian R. Don't bug me: the problem of bacterial contamination of blood components: challenges and solutions [editorial]. Transfusion. 2001;41:1331-1334.
12. Popovsky MA. Transfusion-related acute lung injury. Curr Opin Hematol. 2000;7:402-407.
13. Blajchman MA, Dzik S, Vamvakas EC, et al. Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference [review]. Transfus Med Rev. 2001;15:108-135.
14. Kopko PM, Marshall CS, MacKenzie MR, et al. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA. 2002;287:1968-1971.
15. Leiby DA. Parasites and other emergent infectious agents. In: Stramer S, ed. Blood Safety in the New Millenium. Bethesda, Md: American Association of Blood Banks; 2001:55-78.
16. Leiby DA, Read EJ, Lenes BA, et al. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors. J Infect Dis. 1997; 176:1047-1052.
17. Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med. 2001;344: 1973-1978.
18. Department of Health. Creutzfeldt-Jakob disease (CJD) and bovine spongiform encephalopathy (BSE). Available at: http://www.doh.gov.uk/cjd. Accessibility verified January 8, 2003.
19. Turner ML, Ludlam CA. Variant Creutzfeldt-Jakob disease. Transfus Med Rev. 2000;14:216-222.
20. Dodd RY, Busch MP. Animal models of bovine spongiform encephalopathy and vCJD infectivity in blood: two swallows do not a summer make [editorial]. Transfusion. 2002;42:509-512.
21. Chamberland ME. Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products? Clin Infect Dis. 2002;34:797-805.
22. Busch M, Chamberland M, Epstein J, et al. Over-sight and monitoring of blood safety in the United States. Vox Sang. 1999;77:67-76.
23. Kleinman SH. Hepatitis G virus biology, epidemiology and clinical manifestations: implications for blood safety. Transfus Med Rev. 2001;15:201-221.
24. Cannon MJ, Dollard SC, Smith DK, et al. Blood-borne and sexual transmission of human herpes virus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med. 2001;344:637-644.
25. AuBuchon JP, Kruskall MS. Transfusion safety: realigning efforts with risks. Transfusion. 1997;37:1211-1216.
26. Klein HG. Will blood transfusion ever be safe enough [editorial]? JAMA. 2000;284:238-240.
27. Sibinga CT. Transfusion medicine in developing countries. Transfus Med Rev. 2000;14:269-274.
28. Chamberland ME, Lackritz EM, Busch MP. HIV screening of the blood supply in developed and developing countries. AIDS Rev. 2001;3:24-35.